## costs, long timelines, signiﬁcant technical complexity, and regulatory

hurdles. A recent McKinsey analysis found that large med-tech

companies respond to those hurdles by focusing on incremental

innovations to maintain market share in mature but low-growth

markets. At the other end of the spectrum, there has been an increase

Copyright © 2024 Harvard Business School Publishing. All rights reserved.

11

This document is authorized for use only by Matt O'Donnell (matthew.od11@gmail.com). Copying or posting is an infringement of copyright. Please contact customerservice@harvardbusiness.org or 800-988-0886 for additional copies.